---
figid: PMC9623415__fendo-13-1010092-g001
figtitle: PKC-mediated phosphorylation and activation of the MEK/ERK pathway as a
  mechanism of acquired trastuzumab resistance in HER2-positive breast cancer
organisms:
- Mus musculus
- Rattus norvegicus
- Cerobasis alpha
- Homo sapiens
organisms_ner:
- Mus musculus
- Homo sapiens
- Rattus norvegicus
- Danio rerio
pmcid: PMC9623415
filename: fendo-13-1010092-g001.jpg
figlink: /pmc/articles/PMC9623415/figure/f1/
number: F1
caption: 'Pathways involved in the induced trastuzumab resistance of T15 (log2 FC
  normalized to SKBR3 signals). Similarly expressed protein: light grey; antibody
  not available/poor performance: no fill; overexpressed total protein ≥ 1.5-fold
  (log2 FC ≥ 0.58): light orange; ≥ 2-fold: *; over-represented phosphosite ≥ 1.5-fold:
  orange; ≥ 2-fold: *; predicted active protein: dark red outline.'
papertitle: PKC-mediated phosphorylation and activation of the MEK/ERK pathway as
  a mechanism of acquired trastuzumab resistance in HER2-positive breast cancer.
reftext: Jeanesse Scerri, et al. Front Endocrinol (Lausanne). 2022;13:1010092.
year: '2022'
doi: 10.3389/fendo.2022.1010092
journal_title: Frontiers in Endocrinology
journal_nlm_ta: Front Endocrinol (Lausanne)
publisher_name: Frontiers Media S.A.
keywords: acquired resistance | breast cancer | phospho-profile | PKC/MEK/ERK | signalosome
  | HER2 positive | patient stratification
automl_pathway: 0.9206257
figid_alias: PMC9623415__F1
figtype: Figure
redirect_from: /figures/PMC9623415__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9623415__fendo-13-1010092-g001.html
  '@type': Dataset
  description: 'Pathways involved in the induced trastuzumab resistance of T15 (log2
    FC normalized to SKBR3 signals). Similarly expressed protein: light grey; antibody
    not available/poor performance: no fill; overexpressed total protein ≥ 1.5-fold
    (log2 FC ≥ 0.58): light orange; ≥ 2-fold: *; over-represented phosphosite ≥ 1.5-fold:
    orange; ≥ 2-fold: *; predicted active protein: dark red outline.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Rps6ka1
  - Rps6ka2
  - Pdk1
  - Pdpk1
  - Prkca
  - Mdk
  - Mapk3
  - Mapk1
  - Rps6ka5
  - Akt1
  - Mtor
  - Rps6kb1
  - RPS6KA1
  - RPS6KA2
  - RPS6KA3
  - RPS6KA4
  - RPS6KA5
  - RPS6KA6
  - PDK1
  - PDPK1
  - PRKCA
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - MAPK3
  - MAPK1
  - AKT1
  - AKT2
  - AKT3
  - MTOR
  - RPS6KB1
  - RPS6KB2
  - Ccne1
  - pdk1
  - mapk3
  - akt1
  - mtor
---
